Hans-Riedl-Strasse 21
Feldkirchen 85622
Germany
49 89 459 9140
https://www2.getinge.com/de/uber-uns/investors/pulsion-investor-relation
Settore/i:
Settore:
Impiegati a tempo pieno: 130
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Stephan Haft | MD & MD of Fin., HR, Ops., Logistics, Quality Management, Regulatory Affairs, IT and Director | N/D | N/D | N/D |
PULSION Medical Systems SE engages in the development, manufacture, sale of monitoring, diagnosis, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include PiCCO2Â, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex that offers technology in the field of perioperative medicine; PiCCOÂ, a catheter used to monitor the cardiovascular system; ProAQTÂ, a sensor used in medicine for high-risk patients and high-risk interventions; CeVOXÂ, a technology that enables continuous monitoring of the patient's oxygen balance; LiMONÂ, a technology used to assess and monitor liver function; NICCI for hemodynamic monitoring. The company was founded in 1990 and is based in Feldkirchen, Germany. PULSION Medical Systems SE was a former subsidiary of MAQUET GmbH
L'ISS Governance QualityScore di PULSION Medical Systems SE al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.